Basic Information
| LncRNA/CircRNA Name | SNHG7 |
| Synonyms | NA |
| Region | GRCh38_9:136721366-136728184 |
| Ensemble | ENSG00000233016 |
| Refseq | NR_003672 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | pancreatic cancer |
| ICD-0-3 | C25 |
| Methods | qPCR, Luciferase reporter assay, Western blot |
| Sample | prostate cancer tissues,cell lines (AsPC-1, BxPC-3, SW1990, PANC-1,PaCa-2,HPDE6-C7, HEK293T) |
| Expression Pattern | up-regulated |
| Function Description | it was found that SNHG7 was upregulated in prostate cancer tissues,and played as a ceRNA to regulate the cycle progression and acted as an oncogenic gene through sponging miR-503 |
| Pubmed ID | 30949340 |
| Year | 2019 |
| Title | LncRNA SNHG7 promotes pancreatic cancer proliferation through ID4 by sponging miR-342-3p. |
External Links
| Links for SNHG7 | GenBank HGNC NONCODE |
| Links for pancreatic cancer | OMIM COSMIC |